Wilmington PLC (WIL)
London Exchange · UK · prices in GBX · close of 22 Oct 2026
Key indicators
| Last close | GBX 272.00 |
|---|---|
| 52-week range | 230.00 – 343.00 |
| Return, 1 month / 3 months | −0.4% / −5.2% |
| Return, 1 year / 3 years | −14.3% / −14.2% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 38.0% |
| Worst drawdown (1 year) | -28.0% |
| Average daily value traded | 23.27M GBX |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wilmington plc is a British company that provides information, training and networking services to professional markets. Its businesses serve people working in law, finance, risk and compliance, and healthcare, offering qualifications, training courses, conferences and published guidance. Customers are mainly organisations and professionals who need to keep their knowledge and skills current. The company is based in the United Kingdom and operates through a group of specialist brands rather than a single consumer-facing operation.
On this site Wilmington PLC appears as a stock on the London Exchange (UK), code WIL, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wilmington PLC (WIL) trades on the London Exchange in UK. It last closed at GBX 272.00 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,764 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.3% and over the last three months it fell 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -18.1% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.2% | ||
| 6-month return | 13.3% | ||
| 12-month return, skipping the last month | -14.0% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.0% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 23.27M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.4% |
|---|---|
| 1 month | −0.4% |
| 3 months | −5.2% |
| 6 months | +13.3% |
| 1 year | −14.3% |
| 3 years | −14.2% |
| 5 years | +36.7% |
Signals
| 50-day / 200-day average | 271.70 / 266.49 |
|---|---|
| Golden / death cross (60 days) | Golden, 52 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 10.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Mar 2026 | GBP 0.0310 |
| 30 Oct 2025 | GBP 0.0850 |
| 6 Mar 2025 | GBP 0.0300 |
| 31 Oct 2024 | GBP 0.0830 |
| 29 Feb 2024 | GBP 0.0300 |
| 2 Nov 2023 | GBP 0.0730 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.